Koite Health, the company behind Lumoral®, is initiating a comprehensive research collaboration with Associated Brånemark Osseointegration Centers (ABOC) on the prevention and long-term maintenance of implant patients.

ABOC is an international network of accredited implant centers rooted in Professor Per-Ingvar Brånemark's pioneering work in osseointegration. The network possesses extensive clinical and scientific expertise, as well as a global research and educational environment.

Focus on implant health – even between clinic visits

Long-term implant results depend not only on surgical and prosthetic execution. The health of the tissue around the implant and continuous control of oral biofilm are crucial for long-term success.

This means that a large part of implant care takes place at home between professional follow-ups, where the patient's own effort is decisive.

This is precisely the area that the research collaboration focuses on. The purpose is to investigate and develop structured, preventive care pathways that combine professional clinic follow-up with the patient's daily self-care.

From professional treatment to structured home care

Lumoral® is a light-activated antibacterial home treatment that helps the patient effectively control oral biofilm in the periods between clinic visits.

The research collaboration will, among other things, investigate:

  • How preventive care pathways are best structured around implant patients.

  • How antibacterial home treatment can be included in ongoing maintenance.

  • How professional follow-up and self-care can be combined most optimally.

  • How knowledge and clinical documentation on prevention are built up and shared with clinicians.

The goal is to create a stronger clinical and scientific basis for preventive implant care.

ABOC – an international network with roots in modern implantology

Associated Brånemark Osseointegration Centers was founded in 1989 in Gothenburg by Professor Per-Ingvar Brånemark. Today, the network covers the entire spectrum of implant treatments – from single-tooth treatments to complex rehabilitations and maxillofacial reconstructions.

Through, among other things, Brånemark Academy, the network handles education, certification, and scientific development. It is this deep professional and clinical experience that is now combined with Koite Health's technology.

Statements about the collaboration

Peter Rådqvist – CEO, Koite Health

“The long-term success of an implant is decided as much between visits as in the clinic, and this is where the science of prevention still has room to develop. The collaboration with Brånemark Osseointegration Centers, a network that defined the scientific basis for implantology, allows us to study and document how light-activated antibacterial home care can support the health of the tissue around the implant. The collaboration is built on a shared clinical curiosity and a commitment to strengthening the evidence base.”

Peter Rådqvist
CEO, Koite Health


Robert Gottlander – CEO, Associated Brånemark Osseointegration Centres

“Osseointegration is built on thorough science and long-term observation, and maintaining the health of implants deserves the same attention as the surgery itself. The partnership with Koite Health will allow us to explore evidence-based ways for patients to better protect the health of their peri-implant tissue at home between doctor's visits. This collaboration fits into our mission to raise the standard of care and educate the clinical profession on what truly sustains the long-term success of implant treatment for the patient.”

Robert Gottlander
CEO, Associated Brånemark Osseointegration Centres


Prof. Per-Olov Östman – Associated Brånemark Osseointegration Centres

“Dental implants have an excellent long-term prognosis, and having followed our patients for over 30 years, we know how important healthy peri-implant tissue is for maintaining these results over time.”

“Peri-implant mucositis and peri-implantitis remain significant challenges in implant treatment, and this is where I believe Lumoral contributes something truly valuable to our clinical practice. It is a simple, non-invasive treatment that patients can use at home to support biofilm control and peri-implant health between doctor's visits.”

“Our clinical experience with Lumoral has been very encouraging. We see particular potential in both helping patients maintain healthy tissue around their implants and supporting the management of early signs of inflammation. Equally important, it gives the patient an active role in ensuring the long-term success of their own implant treatment.”

“We look forward to the collaboration with Koite Health and the opportunity to participate in further studies to determine how Lumoral can become an effective part of structured prevention and maintenance protocols for implant patients.”

Prof. Per-Olov Östman
Associated Brånemark Osseointegration Centres (ABOC)

About Lumoral® in the clinic's implant workflow

Lumoral® is a Finnish-developed, clinically documented, and CE-marked medical technology for home use. The treatment uses light-activated antibacterial technology to control biofilm in areas that may be difficult to reach with mechanical toothbrushing.

For clinics working with implant patients, Lumoral® can be an integrated part of a structured prevention and maintenance program.

👉 Do you want to know more about Lumoral® and the possibilities of integrating the treatment into your clinic?

Contact Puredent or read more here →

Latest Stories

This section doesn’t currently include any content. Add content to this section using the sidebar.